MrpJ Directly Regulates Proteus mirabilis Virulence Factors, Including Fimbriae and Type VI Secretion, during Urinary Tract Infection

被引:11
|
作者
Debnath, Irina [1 ]
Stringer, Anne M. [2 ]
Smith, Sara N. [3 ]
Bae, Emily [1 ]
Mobley, Harry L. T. [3 ]
Wade, Joseph T. [2 ,4 ]
Pearson, Melanie M. [1 ,3 ,5 ]
机构
[1] NYU, Dept Microbiol, Med Ctr, New York, NY 10016 USA
[2] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA
[3] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA
[4] SUNY Albany, Dept Biomed Sci, Albany, NY USA
[5] NYU, Dept Urol, Med Ctr, New York, NY 10003 USA
基金
美国国家卫生研究院;
关键词
CAUTI; UTI; bladder; Proteus mirabilis; transcription; regulation; ChIP-seq; fimbriae; pili; COMPLETE GENOME SEQUENCE; COLD-SHOCK PROTEINS; MOUSE MODEL; BIOFILM FORMATION; ESCHERICHIA-COLI; GENE-EXPRESSION; SWARMING MOTILITY; RCS PHOSPHORELAY; LIFE-STYLE; MUTANT;
D O I
10.1128/IAI.00388-18
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Proteus mirabilis is a leading cause of catheter-associated urinary tract infections (CAUTIs) and urolithiasis. The transcriptional regulator MrpJ inversely modulates two critical aspects of P. mirabilis UTI progression: fimbria-mediated attachment and flagellum-mediated motility. Transcriptome data indicated a network of virulence-associated genes under MrpJ's control. Here, we identify the direct gene regulon of MrpJ and its contribution to P. mirabilis pathogenesis, leading to the discovery of novel virulence targets. Chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) was used for the first time in a CAUTI pathogen to probe for in vivo direct targets of MrpJ. Selected MrpJ-regulated genes were mutated and assessed for their contribution to UTI using a mouse model. ChIP-seq revealed a palindromic MrpJ binding sequence and 78 MrpJ-bound regions, including binding sites upstream of genes involved in motility, fimbriae, and a type VI secretion system (T6SS). A combinatorial mutation approach established the contribution of three fimbriae (fim8A, fim14A, and pmpA) to UTI and a new pathogenic role for the T6SS in UTI progression. In conclusion, this study (i) establishes the direct gene regulon and an MrpJ consensus binding site and (ii) led to the discovery of new virulence genes in P. mirabilis UTI, which could be targeted for therapeutic intervention of CAUTI.
引用
收藏
页数:18
相关论文
共 34 条
  • [1] Virulence Factors of Proteus mirabilis Isolated from Urinary Tract Infection Patients
    Mustafa, Harith Ahmed
    Ahmed, Marwa Tariq
    Meri, Marwa Ahmed
    Mustafa, Mohammed Ahmed
    LATIN AMERICAN JOURNAL OF PHARMACY, 2023, 42 : 418 - 421
  • [2] New aspects of the role of MR/P fimbriae in Proteus mirabilis urinary tract infection
    Zunino, P
    Geymonat, L
    Allen, AG
    Preston, A
    Sosa, V
    Maskell, DJ
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2001, 31 (02): : 113 - 120
  • [3] Comparison Between Phenotypic and Genotypic to Some Virulence Factors of Proteus Mirabilis Isolation from Urinary Tract Infection
    Dawood, Muhammad Majbil
    Mahdi, Zainab Hussein
    JOURNAL OF PIONEERING MEDICAL SCIENCES, 2025, 14 (02): : 54 - 58
  • [4] The type III secretion system of Proteus mirabilis HI4320 does not contribute to virulence in the mouse model of ascending urinary tract infection
    Pearson, Melanie M.
    Mobley, Harry L. T.
    JOURNAL OF MEDICAL MICROBIOLOGY, 2007, 56 (10) : 1277 - 1283
  • [5] PROTEUS-MIRABILIS FIMBRIAE - CONSTRUCTION OF AN ISOGENIC PMFA MUTANT AND ANALYSIS OF VIRULENCE IN A CBA MOUSE MODEL OF ASCENDING URINARY-TRACT INFECTION
    MASSAD, G
    LOCKATELL, CV
    JOHNSON, DE
    MOBLEY, HLT
    INFECTION AND IMMUNITY, 1994, 62 (02) : 536 - 542
  • [6] The high-affinity phosphate transporter Pst is a virulence factor for Proteus mirabilis during complicated urinary tract infection
    Jacobsen, Sandra M.
    Lane, Mary C.
    Harro, Jean M.
    Shirtliff, Mark E.
    Mobley, Harry L. T.
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2008, 52 (02): : 180 - 193
  • [7] Proteus mirabilis urinary tract infection and bacteremia: Risk factors, clinical presentation, and outcomes
    Chen, Chi-Yu
    Chen, Yen-Hsu
    Lu, Po-Liang
    Lin, Wei-Ru
    Chen, Tun-Chieh
    Lin, Chun-Yu
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2012, 45 (03) : 228 - 236
  • [8] MOLECULAR DETECTION OF SOME VIRULENCE GENE IN Proteus Mirabilis ISOLATED FROM URINARY TRACT INFECTION IN IRAQ
    Al-khalidy, R. M. S.
    Aburesha, R. A.
    IRAQI JOURNAL OF AGRICULTURAL SCIENCES, 2023, 54 (03): : 709 - 715
  • [9] Virulence of a Proteus mirabilis ATF isogenic mutant is not impaired in a mouse model of ascending urinary tract infection
    Zunino, P
    Geymonat, L
    Allen, AG
    Legnani-Fajardo, C
    Maskell, DJ
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2000, 29 (02): : 137 - 143
  • [10] The Pathogenic Potential of Proteus mirabilis Is Enhanced by Other Uropathogens during Polymicrobial Urinary Tract Infection
    Armbruster, Chelsie E.
    Smith, Sara N.
    Johnson, Alexandra O.
    DeOrnellas, Valerie
    Eaton, Kathryn A.
    Yep, Alejandra
    Mody, Lona
    Wu, Weisheng
    Mobley, Harry L. T.
    INFECTION AND IMMUNITY, 2017, 85 (02)